Treatment for Substance Use Disorder With Co-Occurring Mental Illness
Open accessThe DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.
Abstract
Substance use disorder is a highly prevalent condition, leading to significant morbidity, mortality, and burden on the health care system. Substance use disorders are overrepresented among individuals with a mental illness. The term "dual diagnosis" was introduced by the World Health Organization in the mid-1990s and refers to the co-occurrence of a substance use disorder with mental illness-a more recently used term is "co-occurring disorders." In the past decade, substantial progress has been made toward expanding psychotherapeutic and pharmacotherapeutic treatments for treating co-occurring disorders. Yet management remains a challenge among clinicians and has been a source of confusion and considerable controversy. This review describes the epidemiology and treatment of co-occurring disorders, with a focus on major depressive disorder, anxiety disorders, and attention-deficit hyperactivity disorder. Substance use may make diagnosis of the underlying psychiatric condition difficult, and a period of abstinence may be necessary. Findings from efficacy studies of medications used to treat co-occurring disorders are reviewed, as are results of preliminary studies of newer treatments, such as topiramate, ketamine, noninvasive brain stimulation, and deep brain stimulation. Treatment recommendations that combine medications and psychosocial interventions are summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,380
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
The brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
Avenevoli, S., Swendsen, J., He, J.-P., Burstein, M., & Merikangas, K. R. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.010 · Cited by 1,202
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027
DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen, H.-U. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050015002 · Cited by 967
Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.031 · Cited by 941
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Contingency management for treatment of substance use disorders: a meta‐analysis
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01581.x · Cited by 877
Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., Zhang, H., Smith, S. M., Pickering, R. P., Huang, B., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2132 · Cited by 877
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Childhood and Adolescent Psychiatric Disorders as Predictors of Young Adult Disorders
Copeland, W. E., Shanahan, L., Costello, E. J., & Angold, A. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.85 · Cited by 844
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728
RASMUSSEN, P., & GILLBERG, C. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200011000-00017 · Cited by 728
Kessler, R. C., Adler, L. A., Barkley, R., Biederman, J., Conners, C. K., Faraone, S. V., Greenhill, L. L., Jaeger, S., Secnik, K., Spencer, T., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.001 · Cited by 663
Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey
Grant, B. F., & Harford, T. C. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01160-4 · Cited by 637
Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000512 · Cited by 620
Alcohol promotes dopamine release in the human nucleus accumbens
Boileau, I., Assaad, J., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R. E., & Dagher, A. (2003) · Synapse · doi:10.1002/syn.10226 · Cited by 591
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588
Cognitive therapy of substance abuse
Frances, R. J. (1994) · General Hospital Psychiatry · doi:10.1016/0163-8343(94)90121-x · Cited by 575
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes, E. V., & Levin, F. R. (2004) · JAMA · doi:10.1001/jama.291.15.1887 · Cited by 532
Self-citationTranscranial magnetic stimulation: Diagnostic, therapeutic, and research potential
Rossini, P. M., & Rossi, S. (2007) · Neurology · doi:10.1212/01.wnl.0000250268.13789.b2 · Cited by 529
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519
Volkow, N. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2002.4099 · Cited by 514
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Jayne, M., Ma, Y., Pradhan, K., & Wong, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3371-07.2007 · Cited by 494
Long-term Electrical Capsular Stimulation in Patients with Obsessive-Compulsive Disorder
Nuttin, B. J., Gabriëls, L. A., Cosyns, P. R., Meyerson, B. A., Andréewitch, S., Sunaert, S. G., Maes, A. F., Dupont, P. J., Gybels, J. M., Gielen, F., et al. (2003) · Neurosurgery · doi:10.1227/01.neu.0000064565.49299.9a · Cited by 487
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Efficacy of relapse prevention: A meta-analytic review.
Irvin, J. E., Bowers, C. A., Dunn, M. E., & Wang, M. C. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.4.563 · Cited by 424
Addiction and Brain Reward and Antireward Pathways
Gardner, E. L. (2011) · Advances in Psychosomatic Medicine · doi:10.1159/000324065 · Cited by 417
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
The neurobiology of addiction: a neuroadaptational view relevant for diagnosis
Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397
Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking
Hall, S. M., Reus, V. I., Muñoz, R. F., Sees, K. L., Humfleet, G., Hartz, D. T., Frederick, S., & Triffleman, E. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.683 · Cited by 385
Fluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 357
Addiction and suicide: A review
Yuodelis‐Flores, C., & Ries, R. K. (2015) · The American Journal on Addictions · doi:10.1111/ajad.12185 · Cited by 342
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD)
Sobanski, E. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-1004-4 · Cited by 340
Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD
Wilens, T. E., Martelon, M., Joshi, G., Bateman, C., Fried, R., Petty, C., & Biederman, J. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.01.021 · Cited by 339
Brown, J. M., & Miller, W. R. (1993) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.7.4.211 · Cited by 329
Mood Disorders and Substance Use Disorder: A Complex Comorbidity
Quello, S., Brady, K., & Sonne, S. (2005) · Science & Practice Perspectives · doi:10.1151/spp053113 · Cited by 320
Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300406 · Cited by 315
Amiaz, R., Levy, D., Vainiger, D., Grunhaus, L., & Zangen, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02448.x · Cited by 313
Increased Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine Craving
Wong, D. F., Kuwabara, H., Schretlen, D. J., Bonson, K. R., Zhou, Y., Nandi, A., Brašić, J. R., Kimes, A. S., Maris, M. A., Kumar, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301194 · Cited by 311
Current depression among adults--United States, 2006 and 2008: (664792010-002)
(2010) · PsycEXTRA Dataset · doi:10.1037/e664792010-002 · Cited by 310
Grant, B. F. (1995) · Journal of Substance Abuse · doi:10.1016/0899-3289(95)90017-9 · Cited by 306
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
CONNOR, D. F., FLETCHER, K. E., & SWANSON, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00017 · Cited by 297
Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
Adler, L., & Cohen, J. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.003 · Cited by 290
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 284
Effects of non-invasive neurostimulation on craving: A meta-analysis
Jansen, J. M., Daams, J. G., Koeter, M. W. J., Veltman, D. J., van den Brink, W., & Goudriaan, A. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.009 · Cited by 284
Crawford, M. J., Patton, R., Touquet, R., Drummond, C., Byford, S., Barrett, B., Reece, B., Brown, A., & Henry, J. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17190-0 · Cited by 273
A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in Adults
Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., Polisner, D., Solhkhah, R., Comeau, S., Monuteaux, M. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.282 · Cited by 272
Camprodon, J. A., Martínez-Raga, J., Alonso-Alonso, M., Shih, M.-C., & Pascual-Leone, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.06.002 · Cited by 272
Pettinati, H. M., Oslin, D. W., Kampman, K. M., Dundon, W. D., Xie, H., Gallis, T. L., Dackis, C. A., & O'Brien, C. P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08060852 · Cited by 267
Efficacy of antidepressants in substance use disorders with and without comorbid depression
Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.09.004 · Cited by 261
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Pankratz, V. S., Weaver, A. L., Weber, K. J., Mrazek, D. A., & Jacobsen, S. J. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.3.217 · Cited by 257
Mishra, B. R., Nizamie, S. H., Das, B., & Praharaj, S. K. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02777.x · Cited by 250
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
Buspirone Treatment of Anxious Alcoholics: A Placebo-Controlled Trial
Kranzler, H. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090052008 · Cited by 248
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research
Krupitsky, E. M., & Grinenko, A. Y. (1997) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1997.10400185 · Cited by 246
WILENS, T. E., GIGNAC, M., SWEZEY, A., MONUTEAUX, M. C., & BIEDERMAN, J. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000199027.68828.b3 · Cited by 246
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Cognitive Therapy of Substance Abuse: Theoretical Rationale: (495912006-008)
Wright, F. D., Beck, A. T., Newman, C. F., & Liese, B. S. (1993) · PsycEXTRA Dataset · doi:10.1037/e495912006-008 · Cited by 234
High-Frequency Repetitive Transcranial Magnetic Stimulation Decreases Cigarette Smoking
Eichhammer, P., Johann, M., Kharraz, A., Binder, H., Pittrow, D., Wodarz, N., & Hajak, G. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0815 · Cited by 233
Sertraline Treatment for Alcohol Dependence: Interactive Effects of Medication and Alcoholic Subtype
Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., & Cnaan, A. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200007000-00015 · Cited by 227
Deep brain stimulation in addiction: a review of potential brain targets
Luigjes, J., van den Brink, W., Feenstra, M., van den Munckhof, P., Schuurman, P. R., Schippers, R., Mazaheri, A., De Vries, T. J., & Denys, D. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.114 · Cited by 223
Kranzler, H. R., Burleson, J. A., Brown, J., & Babor, T. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01696.x · Cited by 213
Imipramine Treatment of Alcoholics With Primary Depression: A Placebo-Controlled Clinical Trial
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212
Li, X., Hartwell, K. J., Owens, M., LeMatty, T., Borckardt, J. J., Hanlon, C. A., Brady, K. T., & George, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.003 · Cited by 206
Use of Alcohol and Drugs to Self-Medicate Anxiety Disorders in a Nationally Representative Sample
Bolton, J., Cox, B., Clara, I., & Sareen, J. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000244481.63148.98 · Cited by 206
ABIKOFF, H., HECHTMAN, L., KLEIN, R. G., GALLAGHER, R., FLEISS, K., ETCOVITCH, J., COUSINS, L., GREENFIELD, B., MARTIN, D., & POLLACK, S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000128797.91601.1a · Cited by 198
Wilens, T. E., Haight, B. R., Horrigan, J. P., Hudziak, J. J., Rosenthal, N. E., Connor, D. F., Hampton, K. D., Richard, N. E., & Modell, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.027 · Cited by 193
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189
Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014) · Addiction · doi:10.1111/add.12369 · Cited by 188
Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., Babb, D., Bai, Y., Eberly, L. E., Nunes, E. V., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.41 · Cited by 179
Self-citationValproate in combat-related posttraumatic stress disorder.
Fesler, F. A. (1991) · PubMed · Cited by 170
De Ridder, D., Vanneste, S., Kovacs, S., Sunaert, S., & Dom, G. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.074 · Cited by 169
Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D., Ocepek-Welikson, K., Koenig, T., Brady, R., McGrath, P. J., & Woody, G. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.153 · Cited by 164
Politi, E., Fauci, E., Santoro, A., & Smeraldi, E. (2008) · The American Journal on Addictions · doi:10.1080/10550490802139283 · Cited by 161
Treatment of depression in patients with opiate dependence
Nunes, E. V., Sullivan, M. A., & Levin, F. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.037 · Cited by 158
Self-citationA Placebo‐Controlled Trial of Buspirone in Anxious Inpatient Alcoholics
Malcolm, R., Anton, R. F., Randall, C. L., Johnston, A., Brady, K., & Thevos, A. (1992) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb00691.x · Cited by 157
Johnson, B. A., Ait-Daoud, N., Akhtar, F. Z., & Ma, J. Z. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.9.905 · Cited by 156
Brain Imaging Studies in Mood and Anxiety Disorders: Special Emphasis on the Amygdala
ANAND, A., & SHEKHAR, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07095.x · Cited by 156
Risk of Death From Accidental Overdose Associated With Psychiatric and Substance Use Disorders
Bohnert, A. S. B., Ilgen, M. A., Ignacio, R. V., McCarthy, J. F., Valenstein, M., & Blow, F. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10101476 · Cited by 156
Ye, T., Peng, J., Nie, B., Gao, J., Liu, J., Li, Y., Wang, G., Ma, X., Li, K., & Shan, B. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.04.058 · Cited by 156
Kuhn, J., Gründler, T. O. J., Bauer, R., Huff, W., Fischer, A. G., Lenartz, D., Maarouf, M., Bührle, C., Klosterkötter, J., Ullsperger, M., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00337.x · Cited by 154
Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: a case report
Zhou, H., Xu, J., & Jiang, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.012 · Cited by 148
Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction
Kuhn, J., Möller, M., Treppmann, J. F., Bartsch, C., Lenartz, D., Gruendler, T. O. J., Maarouf, M., Brosig, A., Barnikol, U. B., Klosterkötter, J., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.196 · Cited by 147
Dakwar, E., Levin, F., Foltin, R. W., Nunes, E. V., & Hart, C. L. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.009 · Cited by 143
Self-citationPilot randomized double blind placebo‐controlled study of dexamphetamine for cocaine dependence
Shearer, J., Wodak, A., Van Beek, I., Mattick, R. P., & Lewis, J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00447.x · Cited by 141
Valencia-Alfonso, C.-E., Luigjes, J., Smolders, R., Cohen, M. X., Levar, N., Mazaheri, A., van den Munckhof, P., Schuurman, P. R., van den Brink, W., & Denys, D. A. J. P. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.013 · Cited by 138
Hesse, M. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-6 · Cited by 130
Fluoxetine treatment of cocaine-dependent patients with major depressive disorder
Schmitz, J. M., Averill, P. M., Stotts, A. L., Moeller, F. G., Rhoades, H. M., & Grabowski, J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00208-8 · Cited by 130
Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence
Pettinati, H. M., Volpicelli, J. R., Luck, G., Kranzler, H. R., Rukstalis, M. R., & Cnaan, A. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00005 · Cited by 126
Alcohol use disorders and the course of depressive and anxiety disorders
Boschloo, L., Vogelzangs, N., van den Brink, W., Smit, J. H., Veltman, D. J., Beekman, A. T. F., & Penninx, B. W. J. H. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.097550 · Cited by 126
Johnson, B. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1188 · Cited by 125
Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence
Höppner, J., Broese, T., Wendler, L., Berger, C., & Thome, J. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.598383 · Cited by 122
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Bartoli, F., Riboldi, I., Crocamo, C., Brita, C. D., Clerici, M., & Carrà, G. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.010 · Cited by 121
Brunelin, J., Jalenques, I., Trojak, B., Attal, J., Szekely, D., Gay, A., Januel, D., Haffen, E., Schott-Pethelaz, A.-M., Brault, C., et al. (2014) · Brain Stimulation · doi:10.1016/j.brs.2014.07.040 · Cited by 119
Alegría, A. A., Hasin, D. S., Nunes, E. V., Liu, S.-M., Davies, C., Grant, B. F., & Blanco, C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05328gry · Cited by 115
Non-random relation between drugs of abuse and psychiatric diagnosis
McLellan, A. T., & Druley, K. A. (1977) · Journal of Psychiatric Research · doi:10.1016/0022-3956(77)90007-3 · Cited by 113
Han, Y., Chen, J., Zou, D., Zheng, P., Li, Q., Wang, H., Li, P., Zhou, X., Zhang, Y., Liu, Y., et al. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s117146 · Cited by 113
Reduction of dorsolateral prefrontal cortex gray matter in late-life depression
Chang, C.-C., Yu, S.-C., McQuoid, D. R., Messer, D. F., Taylor, W. D., Singh, K., Boyd, B. D., Krishnan, K. R. R., MacFall, J. R., Steffens, D. C., et al. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.01.003 · Cited by 112
Moak, D. H., Anton, R. F., Latham, P. K., Voronin, K. E., Waid, R. L., & Durazo-Arvizu, R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095346.32154.41 · Cited by 112
Daley, D. C., Salloum, I. M., Zuckoff, A., Kirisci, L., & Thase, M. E. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1611 · Cited by 109
Müller, U., Sturm, V., Voges, J., Heinze, H.-J., Galazky, I., Büntjen, L., Heldmann, M., Frodl, T., Steiner, J., & Bogerts, B. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-104507 · Cited by 108
Herremans, S. C., Baeken, C., Vanderbruggen, N., Vanderhasselt, M., Zeeuws, D., Santermans, L., & Raedt, R. D. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.021 · Cited by 105
Dakwar, E., Hart, C. L., Levin, F. R., Nunes, E. V., & Foltin, R. W. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.39 · Cited by 105
Self-citationTOLLEFSON, G. D., MONTAGUE-CLOUSE, J., & TOLLEFSON, S. L. (1992) · Current Opinion in Cardiology · doi:10.1097/00001573-199202000-00004 · Cited by 104
Kedzior, Azorina, V., & Reitz, S. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s58405 · Cited by 94
Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence
Shearer, J., Wodak, A., Mattick, R. P., Van Beek, I., Lewis, J., Hall, W., & Dolan, K. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96912898.x · Cited by 93
Batki, S. L., Pennington, D. L., Lasher, B., Neylan, T. C., Metzler, T., Waldrop, A., Delucchi, K., & Herbst, E. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12496 · Cited by 91
Fitzgerald, P. B., Hoy, K., Gunewardene, R., Slack, C., Ibrahim, S., Bailey, M., & Daskalakis, Z. J. (2011) · Psychological Medicine · doi:10.1017/s0033291710001923 · Cited by 91
Cortical Hypoexcitability in Chronic Smokers? A Transcranial Magnetic Stimulation Study
Lang, N., Hasan, A., Sueske, E., Paulus, W., & Nitsche, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301645 · Cited by 90
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients
Randall, C. L., Johnson, M. R., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., Brady, K. T., & M.D., J. R. D. (2001) · Depression and Anxiety · doi:10.1002/da.1077 · Cited by 88
TOLLEFSON, G. D., MONTAGUE-CLOUSE, J., & TOLLEFSON, S. L. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00004 · Cited by 88
Imipramine as Treatment for Depression in Addicts
Kleber, H. D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010059007 · Cited by 87
Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., & Nicholson, G. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.8.913 · Cited by 87
Herremans, S. C., Vanderhasselt, M.-A., De Raedt, R., & Baeken, C. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt054 · Cited by 87
Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
Roy, A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00509-x · Cited by 86
Li, X., Malcolm, R. J., Huebner, K., Hanlon, C. A., Taylor, J. J., Brady, K. T., George, M. S., & See, R. E. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.08.012 · Cited by 82
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
Petrakis, I., M. Carroll, K., Nich, C., Gordon, L., Kosten, T., & Rounsaville, B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00032-5 · Cited by 81
Blanco, C., Olfson, M., Goodwin, R. D., Ogburn, E., Liebowitz, M. R., Nunes, E. V., & Hasin, D. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0810 · Cited by 81
Deep Brain Stimulation for Refractory Cocaine Dependence
Gonçalves-Ferreira, A., do Couto, F. S., Campos, A. R., Neto, L. L., Gonçalves-Ferreira, D., & Teixeira, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.023 · Cited by 80
Hechtman, L. T., Abikoff, H., Klein, R. G., Greenfield, B. J., Etcovitch, J., Cousins, L. S., Fleiss, K., Weiss, M. D., & Pollack, S. Z. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000128785.52698.19 · Cited by 78
Relationship between anxiety disorders and opiate dependence— A systematic review of the literature
Fatseas, M., Denis, C., Lavie, E., & Auriacombe, M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.12.003 · Cited by 75
Moreno-López, L., Stamatakis, E. A., Fernández-Serrano, M. J., Gómez-Río, M., Rodríguez-Fernández, A., Pérez-García, M., & Verdejo-García, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039830 · Cited by 72
Buspirone in the Treatment of Alcohol Dependence: A Placebo‐Controlled Trial
Malec, E., Malec, T., Gagné, M., & Dongier, M. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01644.x · Cited by 70
Cassidy, T. A., Varughese, S., Russo, L., Budman, S. H., Eaton, T. A., & Butler, S. F. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712468486 · Cited by 68
Gordon, S. M., Tulak, F., & Troncale, J. (2004) · Journal of Addictive Diseases · doi:10.1300/j069v23n04_03 · Cited by 67
Methylphenidate and Dextroamphetamine Abuse in Substance‐Abusing Adolescents
Williams, R. J., Goodale, L. A., Shay‐Fiddler, M. A., Gloster, S. P., & Chang, S. Y. (2004) · The American Journal on Addictions · doi:10.1080/10550490490483053 · Cited by 64
Comorbidity of Alcohol, Drug, and Psychiatric Disorders: Epidemiology
(2004) · Dual Diagnosis and Psychiatric Treatment · doi:10.3109/9780203017616-7 · Cited by 60
Biederman, J., Swanson, J. M., Wigal, S. B., Boellner, S. W., Earl, C. Q., Lopez, F. A., & Modafinil ADHD Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0506 · Cited by 58
LONG-TERM ELECTRICAL CAPSULAR STIMULATION IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER
Nuttin, B. J., Gabriëls, L. A., Cosyns, P. R., Meyerson, B. A., Andréewitch, S., Sunaert, S. G., Maes, A. F., Dupont, P. J., Gybels, J. M., Gielen, F., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000333764.20575.d6 · Cited by 58
Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Richards, E. M., Vande Voort, J. L., Ballard, E. D., Brutsche, N. E., Furey, M. L., & Zarate, C. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu039 · Cited by 56
Venlafaxine in children and adolescents with attention deficit hyperactivity disorder
MOTAVALLI MUKADDES, N., & ABALI, O. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01199.x · Cited by 54
Green, K. M., Zebrak, K. A., Fothergill, K. E., Robertson, J. A., & Ensminger, M. E. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.06.008 · Cited by 50
Rapinesi, C., Curto, M., Kotzalidis, G. D., CASALE, A. D., Serata, D., Ferri, V. R., Pietro, S. D., Scatena, P., Bersani, F. S., Raccah, R. N., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.015 · Cited by 49
Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation
White, R. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522299.x · Cited by 49
Krupitsky, E. M., Grineko, A. Y., Berkaliev, T. N., Paley, A. I., Tetrov, U. N., Mushkov, K. A., & Borodikin, Y. S. (1992) · Alcoholism Treatment Quarterly · doi:10.1300/j020v09n01_09 · Cited by 49
Topiramate in Combat-Related Posttraumatic Stress Disorder
Alderman, C. P., McCarthy, L. C., Condon, J. T., Marwood, A. C., & Fuller, J. R. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l578 · Cited by 47
Rapinesi, C., Kotzalidis, G. D., Serata, D., Del Casale, A., Bersani, F. S., Solfanelli, A., Scatena, P., Raccah, R. N., Brugnoli, R., Digiacomantonio, V., et al. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12m01438 · Cited by 33
Use of transcranial magnetic stimulation to influence behavior
Kluger, B. M., & Triggs, W. J. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0076-5 · Cited by 27
Assessment and Treatment of Anxiety Disorders and Co-Morbid Alcohol/Other Drug Dependency
McKeehan, M. B., & Martin, D. (2002) · Alcoholism Treatment Quarterly · doi:10.1300/j020v20n01_03 · Cited by 11
Research works printed but not linked: 6
- Centers for Disease Control and Prevention (CDC), 2010, Morb Mortal Wkly Rep, 59, 1229
- Hasin DS, 1998, Drug Alcohol Depend, 39, 197
- 10.1111/j.1530-0277.2000.tb04648.x · doi:10.1111/j.1530-0277.2000.tb04648.x · Paper page
- 10.1037/0893-164X.7.4.211 · DOI · Paper page
- Niciu MJ, 2014, Int J Neuropsychopharmacol, 18, pyu039
- Rapinesi C, 2013, Prim Care Companion CNS Disord, 15, PCC.12m01438
Cited by
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
“Pharmacological interventions play a pivotal role in the treatment of SUDs and psychiatric conditions [22].”
BackgroundLevitt, E. E., Syan, S. K., Sousa, S., Costello, M. J., Rush, B., Samokhvalov, A. V., McCabe, R. E., Kelly, J., & MacKillop, J. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106649 · Cited by 35
Emerging strategies and clinical recommendations for the management of novel depression subtypes
Chiappini, S., Sampogna, G., Ventriglio, A., Menculini, G., Ricci, V., Pettorruso, M., Volpe, U., & Martinotti, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2470973 · Cited by 24
Icick, R., Moggi, F., Slobodin, O., Dom, G., Matthys, F., van den Brink, W., LEVIN, F. R., Blankers, M., Kaye, S. S., Demetrovics, Z., et al. (2020) · European Addiction Research · doi:10.1159/000508546 · Cited by 28
Self-citationBarriers to retention in substance use treatment: Validation of a new, theory-based scale
Zemore, S. E., Ware, O. D., Gilbert, P. A., & Pinedo, M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108422 · Cited by 21
Metadata
- Authors
- Iqbal, M. N., Levin, C. J., & Levin, F. R.
- Affiliations
- New York State Psychiatric Institute (US)
- Venue
- Focus
- Published
- 2019-04
- Volume
- 17
- Issue
- 2
- Pages
- 88-97
- ISSN
- 1541-4094 (ISSN-L)
- 1541-4108
- PMC
- PMC6526999
- OpenAlex
- W2938661501
- Cited by
- 66
- References
- 169
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 14 · 2023: 10 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 2
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- FOCUS The Journal of Lifelong Learning in Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K24DA029647, T32DA007294)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- substance use disorders, co-occurring disorders, dual diagnosis, major depressive disorder, anxiety disorders, attention deficit hyperactivity disorder, pharmacotherapy, psychotherapy, topiramate, ketamine, non-invasive brain stimulation, deep brain stimulation, abstinence, comorbidities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.